Cancer diseases are among the world’s leading causes of death, and this global burden is expected to rise in the next two decades. Researchers have been focusing on gene treatment strategy to curb this growing number. To guarantee the success of the gene therapy strategy, therefore, it is essential to develop a suitable delivery agent, notably a viral vector